Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P15
Within normal range
vs 5Y Ago
-4.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -54.21% |
| Q2 2025 | -1.64% |
| Q1 2025 | -62.04% |
| Q4 2024 | 16.56% |
| Q3 2024 | -41.06% |
| Q2 2024 | 679.70% |
| Q1 2024 | 12.51% |
| Q4 2023 | 483.31% |
| Q3 2023 | -97.82% |
| Q2 2023 | -75.08% |
| Q1 2023 | 35.35% |
| Q4 2022 | -55.05% |
| Q3 2022 | -33.59% |
| Q2 2022 | -28.85% |
| Q1 2022 | -11.50% |
| Q4 2021 | -28.81% |
| Q3 2021 | -11.38% |
| Q2 2021 | 123.40% |
| Q1 2021 | -35.75% |
| Q4 2020 | 894.65% |
| Q3 2020 | 12.63% |
| Q2 2020 | 0.00% |
| Q1 2020 | 100.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |